214 related articles for article (PubMed ID: 17969357)
1. [ALS and microglia--a player for non-cell-autonomous neuron death].
Yamanaka K; Yamashita H
Brain Nerve; 2007 Oct; 59(10):1163-70. PubMed ID: 17969357
[TBL] [Abstract][Full Text] [Related]
2. [Animal models of amyotrophic lateral sclerosis].
Yamanaka K
Rinsho Shinkeigaku; 2007 Nov; 47(11):934-7. PubMed ID: 18210840
[TBL] [Abstract][Full Text] [Related]
3. [Implications of successful immunotherapy in ALS model mice].
Urushitani M
Brain Nerve; 2008 Jun; 60(6):643-51. PubMed ID: 18567360
[TBL] [Abstract][Full Text] [Related]
4. Onset and progression in inherited ALS determined by motor neurons and microglia.
Boillée S; Yamanaka K; Lobsiger CS; Copeland NG; Jenkins NA; Kassiotis G; Kollias G; Cleveland DW
Science; 2006 Jun; 312(5778):1389-92. PubMed ID: 16741123
[TBL] [Abstract][Full Text] [Related]
5. System xC- is a mediator of microglial function and its deletion slows symptoms in amyotrophic lateral sclerosis mice.
Mesci P; Zaïdi S; Lobsiger CS; Millecamps S; Escartin C; Seilhean D; Sato H; Mallat M; Boillée S
Brain; 2015 Jan; 138(Pt 1):53-68. PubMed ID: 25384799
[TBL] [Abstract][Full Text] [Related]
6. Gene transfer demonstrates that muscle is not a primary target for non-cell-autonomous toxicity in familial amyotrophic lateral sclerosis.
Miller TM; Kim SH; Yamanaka K; Hester M; Umapathi P; Arnson H; Rizo L; Mendell JR; Gage FH; Cleveland DW; Kaspar BK
Proc Natl Acad Sci U S A; 2006 Dec; 103(51):19546-51. PubMed ID: 17164329
[TBL] [Abstract][Full Text] [Related]
7. The NADPH oxidase pathway is dysregulated by the P2X7 receptor in the SOD1-G93A microglia model of amyotrophic lateral sclerosis.
Apolloni S; Parisi C; Pesaresi MG; Rossi S; Carrì MT; Cozzolino M; Volonté C; D'Ambrosi N
J Immunol; 2013 May; 190(10):5187-95. PubMed ID: 23589615
[TBL] [Abstract][Full Text] [Related]
8. Oxidized/misfolded superoxide dismutase-1: the cause of all amyotrophic lateral sclerosis?
Kabashi E; Valdmanis PN; Dion P; Rouleau GA
Ann Neurol; 2007 Dec; 62(6):553-9. PubMed ID: 18074357
[TBL] [Abstract][Full Text] [Related]
9. ALS: a disease of motor neurons and their nonneuronal neighbors.
Boillée S; Vande Velde C; Cleveland DW
Neuron; 2006 Oct; 52(1):39-59. PubMed ID: 17015226
[TBL] [Abstract][Full Text] [Related]
10. Replacement of microglial cells using Clodronate liposome and bone marrow transplantation in the central nervous system of SOD1(G93A) transgenic mice as an in vivo model of amyotrophic lateral sclerosis.
Lee JC; Seong J; Kim SH; Lee SJ; Cho YJ; An J; Nam DH; Joo KM; Cha CI
Biochem Biophys Res Commun; 2012 Feb; 418(2):359-65. PubMed ID: 22269142
[TBL] [Abstract][Full Text] [Related]
11. The proinflammatory action of microglial P2 receptors is enhanced in SOD1 models for amyotrophic lateral sclerosis.
D'Ambrosi N; Finocchi P; Apolloni S; Cozzolino M; Ferri A; Padovano V; Pietrini G; Carrì MT; Volonté C
J Immunol; 2009 Oct; 183(7):4648-56. PubMed ID: 19734218
[TBL] [Abstract][Full Text] [Related]
12. Human Cu/Zn superoxide dismutase (SOD1) overexpression in mice causes mitochondrial vacuolization, axonal degeneration, and premature motoneuron death and accelerates motoneuron disease in mice expressing a familial amyotrophic lateral sclerosis mutant SOD1.
Jaarsma D; Haasdijk ED; Grashorn JA; Hawkins R; van Duijn W; Verspaget HW; London J; Holstege JC
Neurobiol Dis; 2000 Dec; 7(6 Pt B):623-43. PubMed ID: 11114261
[TBL] [Abstract][Full Text] [Related]
13. Oxidative stress, mutant SOD1, and neurofilament pathology in transgenic mouse models of human motor neuron disease.
Tu PH; Gurney ME; Julien JP; Lee VM; Trojanowski JQ
Lab Invest; 1997 Apr; 76(4):441-56. PubMed ID: 9111507
[TBL] [Abstract][Full Text] [Related]
14. Motor neuron dysfunction in a mouse model of ALS: gender-dependent effect of P2X7 antagonism.
Cervetto C; Frattaroli D; Maura G; Marcoli M
Toxicology; 2013 Sep; 311(1-2):69-77. PubMed ID: 23583883
[TBL] [Abstract][Full Text] [Related]
15. IL-10 Controls Early Microglial Phenotypes and Disease Onset in ALS Caused by Misfolded Superoxide Dismutase 1.
Gravel M; Béland LC; Soucy G; Abdelhamid E; Rahimian R; Gravel C; Kriz J
J Neurosci; 2016 Jan; 36(3):1031-48. PubMed ID: 26791230
[TBL] [Abstract][Full Text] [Related]
16. Oxidation versus aggregation - how do SOD1 mutants cause ALS?
Cleveland DW; Liu J
Nat Med; 2000 Dec; 6(12):1320-1. PubMed ID: 11100110
[No Abstract] [Full Text] [Related]
17. Protein disulfide isomerase in ALS mouse glia links protein misfolding with NADPH oxidase-catalyzed superoxide production.
Jaronen M; Vehviläinen P; Malm T; Keksa-Goldsteine V; Pollari E; Valonen P; Koistinaho J; Goldsteins G
Hum Mol Genet; 2013 Feb; 22(4):646-55. PubMed ID: 23118353
[TBL] [Abstract][Full Text] [Related]
18. Transgenics, toxicity and therapeutics in rodent models of mutant SOD1-mediated familial ALS.
Turner BJ; Talbot K
Prog Neurobiol; 2008 May; 85(1):94-134. PubMed ID: 18282652
[TBL] [Abstract][Full Text] [Related]
19. Mitochondrial dysfunction and its role in motor neuron degeneration in ALS.
Manfredi G; Xu Z
Mitochondrion; 2005 Apr; 5(2):77-87. PubMed ID: 16050975
[TBL] [Abstract][Full Text] [Related]
20. Wild-type nonneuronal cells extend survival of SOD1 mutant motor neurons in ALS mice.
Clement AM; Nguyen MD; Roberts EA; Garcia ML; Boillée S; Rule M; McMahon AP; Doucette W; Siwek D; Ferrante RJ; Brown RH; Julien JP; Goldstein LS; Cleveland DW
Science; 2003 Oct; 302(5642):113-7. PubMed ID: 14526083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
